References
- Zandstra SM, Furer JW, van de Lisdonk EH, et al. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 2002;37:139-44
- Hogan DB, Maxwell CJ, Fung TS, et al. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can J Clin Pharmacol 2003;10:72-7
- Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 2004;3:485-93
- Alvarenga JM, Loyola Filho AI, Firmo JO, et al. Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambuí Health and Aging Study (BHAS). Rev Bras Psiquiatr 2008;30:7-11
- Cheng JS, Huang WF, Lin KM, et al. Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan. Int J Geriatr Psychiatry 2008;23:618-24
- Passaro A, Volpato S, Romagnoni F, et al. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell'Anziano. J Clin Epidemiol 2000;53:1222-9
- Kao CH, Sun LM, Su KP, et al. Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan. J Clin Psychiatry 2012;73:e555-60
- Kripke DF. Risks of chronic hypnotic use. National Library of Medicine Bookshelf ID: NBK6630. Available at: http://www.ncbi.nlm,nih.gov/bookshelf/br.fcgi?book=eurekah&part=A28844 [Last accessed 11 January 2012]
- Harnod T, Lin CL, Sung FC, et al. An association between benzodiazepine use and occurrence of benign brain tumors. J Neurol Sci 2014;336:8-12
- Wang SJ, Chung CS, Chankrachang S, et al. Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis. Headache 2008;48:1356-65
- Harnod T, Wang YC, Kao CH. Association of migraine and sleep related breathing disorder: a population-based cohort study. Medicine (Baltimore) 2015;94:e1506
- Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 2005;45:904-10
- Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008;7:354-61
- Pompili M, Cosimo DD, Innamorati M, et al. Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicidal risk. J Headache Pain 2009;10:283-90
- Mendelson WB. Clinical distinctions between long-acting and short-acting benzodiazepines J Clin Psychiatry 1992;53:4-9
- World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology: ATC classification index with DDDs and Guidelines for ATC classification and DDD assignment. Oslo, Norway: Norwegian Institute of Public Health, 2006
- Yeh CC, Wang HH, Chou YC, et al. High risk of gastrointestinal hemorrhage in patients with epilepsy: a nationwide cohort study. Mayo Clin Proc 2013;88:1091-8
- Cheung RT. Prevalence of migraine, tension-type headache, and other headaches in Hong Kong. Headache 2000;40:473-9
- Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-57
- Stovner LJ, Zwart JA, Hagen K, et al. Epidemiology of headache in Europe. Eur J Neurol 2006;13:333-45
- Scher AI, Terwindt GM, Picavet HS, et al. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-20
- Metso TM, Tatlisumak T, Debette S, et al. Migraine in cervical artery dissection and ischemic stroke patients. Neurology 2012;78:1221-8
- Murinova N, Krashin DL, Lucas S. Vascular risk in migraineurs: interaction of endothelial and cortical excitability factors. Headache 2014;54:583-90
- deVries B, Frants RR, Ferrari MD, et al. Molecular genetics of migraine. Hum Genet 2009;126:115-32
- Vecchia D, Pietrobon D. Migraine: a disorder of brain excitatory–inhibitory balance? Trends Neurosci 2012;35:507-20
- Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today 2003;8:445-50
- Puppe A, Limmroth V. GABAergic drugs for the treatment of migraine. CNS Neurol Disord Drug Targets 2007;6:247-50
- Vgontzas AN, Kales A, Bixler EO. Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics. Pharmacology 1995;51:205-23
- Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004;65(Suppl 5):7-12
- Chouinard G, Chouinard VA. New classification of selective serotonin reuptake inhibitor withdrawal. Psychother Psychosom 2015;84:63-71
- Cloos JM, Bocquet V, Rolland-Portal I, et al. Hypnotics and triazolobenzodiazepines – best predictors of high-dose benzodiazepine use: results from the Luxembourg National Health Insurance Registry. Psychother Psychosom 2015;84:273-83
- Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20:236-42